BioRadar operates a continuously running, AI-powered biological intelligence service that detects emerging biological threats before they spread and delivers decision-ready intelligence to public health and private sector leaders. The platform combines threat-agnostic detection across known, novel, and engineered pathogens with real-time risk characterization, addressing the critical gap between outbreak emergence and current reactive detection systems. BioRadar's service is designed to compress detection timelines from weeks to hours, as evidenced by its analysis of the 2026 hantavirus outbreak where a three-week identification gap preceded containment failure.
Funding
Funding not disclosed
Founders
Product
Problem
Engineering pathogens has become fast, cheap, and accessible, while natural outbreaks are accelerating due to climate change, urbanization, and global travel. The number of BSL-3 and BSL-4 laboratories has doubled worldwide since 2020, yet current detection systems remain reactive, episodic, and fragmented—by the time a threat is identified, the window for early intervention has often closed, as seen in the 2026 hantavirus outbreak where a three-week gap between first death and confirmed identification allowed 25 percent of passengers to disembark.
Solution
BioRadar provides America's first continuously operating, AI-enabled biological intelligence service designed to detect emerging threats before they spread and characterize risk in real time. The platform is threat-agnostic, detecting known pathogens, new variants, and previously unknown or engineered threats rather than relying on a limited list of pre-specified diseases. BioRadar delivers decision-ready intelligence to those who need it most, enabling early intervention and containment. The service is built to compress detection timelines from days or weeks to hours, fundamentally shifting biological threat response from reactive to proactive.
Target Audience
Primary customers include public health agencies, government organizations, and large employers seeking early visibility into emerging biological threats to protect workforce health and ensure business continuity.
Features
- Threat-agnostic detection engine capable of identifying known pathogens, new variants, and previously unknown or engineered threats
- Continuously operating AI-enabled surveillance that runs without interruption, eliminating the episodic gaps in traditional monitoring systems
- Real-time risk characterization and intelligence delivery designed for decision-makers in public health and workforce preparedness
- Detection capability engineered to identify biological threats within hours rather than the current standard of days or weeks
- Partnership framework with employer and public health organizations to incorporate workforce needs, business continuity, and public health priorities into intelligence tool development